Literature DB >> 31852863

The Asia-Pacific Society of Cardiology (APSC) Expert Committee Consensus Recommendations for Assessment of Suspected Acute Coronary Syndrome Using High-Sensitivity Cardiac Troponin T in the Emergency Department.

Wei Chieh Jack Tan1,2, Kenji Inoue3, Laila AbdelWareth4, Evangelos Giannitsis5, Sazzli Kasim6, Masayuki Shiozaki3, Tar Choon Aw7, Federick Cheng8, Ho Thuong Dung9, Yi-Heng Li10, Swee Han Lim11, Antonia Anna Lukito12, Martin Than13, Fang-Yeh Chu14,15,16, Tom Devasia17, Chien-Chang Lee18, Arintaya Phrommintikul19, Jong-Chan Youn20, Derek P Chew21.   

Abstract

The Asia-Pacific Society of Cardiology (APSC) high-sensitivity troponin T (hs-TnT) consensus recommendations and rapid algorithm were developed to provide guidance for healthcare professionals in the Asia-Pacific region on assessing patients with suspected acute coronary syndrome (ACS) using a hs-TnT assay. Experts from Asia-Pacific convened in 2 meetings to develop evidence-based consensus recommendations and an algorithm for appropriate use of the hs-TnT assay. The Expert Committee defined a cardiac troponin assay as a high-sensitivity assay if the total imprecision is ≤10% at the 99th percentile of the upper reference limit and measurable concentrations below the 99th percentile are attainable with an assay at a concentration value above the assay's limit of detection for at least 50% of healthy individuals. Recommendations for single-measurement rule-out/rule-in cutoff values, as well as for serial measurements, were also developed. The Expert Committee also adopted similar hs-TnT cutoff values for men and women, recommended serial hs-TnT measurements for special populations, and provided guidance on the use of point-of-care troponin T devices in individuals suspected of ACS. These recommendations should be used in conjunction with all available clinical evidence when making the diagnosis of ACS.

Entities:  

Keywords:  Acute coronary syndrome; Asia-Pacific; Consensus recommendations; High-sensitivity troponin T

Mesh:

Substances:

Year:  2019        PMID: 31852863     DOI: 10.1253/circj.CJ-19-0874

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  2 in total

1.  Non-invasive skin cholesterol testing: a potential proxy for LDL-C and apoB serum measurements.

Authors:  Jiacheng Lai; Yongsheng Han; Chongjian Huang; Bin Li; Jingshu Ni; Meili Dong; Yikun Wang; Qingtong Wang
Journal:  Lipids Health Dis       Date:  2021-10-17       Impact factor: 3.876

2.  Management of Acute Coronary Syndrome With a Bleeding Intra-Tumoral Hepatocellular Carcinoma: A Case Report.

Authors:  Ganesh Manudhane; Ria Mehta; Shamshersingh Chauhan; Maharudra Kumbhar
Journal:  Cureus       Date:  2022-08-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.